| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 02/01/2007 | US20070027084 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070027083 Human growth hormone aqueous formulation |
| 02/01/2007 | US20070027082 Intracellular interleukin-1 receptor antagonist and uses thereof |
| 02/01/2007 | US20070027081 small molecules and peptide mimics of LIM mineralization proteins, particularly LMP-1, to overcome the dose-related translational barriers for BMP-2 therapeutics |
| 02/01/2007 | US20070027080 Method for treatment of vitiligo |
| 02/01/2007 | US20070027079 GHRP 2 strips |
| 02/01/2007 | US20070027078 Isolated proteins from a traditional Chinese medicine Yuzhu and use thereof |
| 02/01/2007 | US20070027077 Pharmaceutical compositions comprising factor VII polypeptides and factor XI polypeptides |
| 02/01/2007 | US20070027076 Use of fumaric acid derivatives for treating cardiac insufficiency, and asthma |
| 02/01/2007 | US20070027075 Compositions and methods for targeted drug delivery |
| 02/01/2007 | US20070027074 Peptide dimer bonded to polyethylene glycol through amide groups; insufficient or defective red blood cell production |
| 02/01/2007 | US20070027073 Long-acting derivatives of pyy agonists |
| 02/01/2007 | US20070027072 Pharmaceutical compositions comprising cyclosporins |
| 02/01/2007 | US20070027071 HCV NS3 protease inhibitors |
| 02/01/2007 | US20070027070 inhibiting norepinephrine uptake in a mammal in need of analgesia by administering 2',6'-dimethyl-Tyr-D-Arg-Phe-Lys-NH2 stimulants |
| 02/01/2007 | US20070027069 Glucan-protein complex extracted from grifola (Maitake) |
| 02/01/2007 | US20070027068 Forming a convalent conjugate of a peptide, EPO, removing X2 or a saccharyl subunit thereof from peptide forming a truncated glycan; contacting truncated glycan with glycosyltransferase and modified sugar donor under conditions suitable for glycosyltransferase to transfer a modified sugar moiety |
| 02/01/2007 | US20070027067 Transition-state Inhibitors of Pin1, alpha-Ketoamide-containing peptidomimetics, and synthesis thereof |
| 02/01/2007 | US20070027066 Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/01/2007 | US20070027065 Modified 2' and 3'-nucleoside prodrugs for treating Flaviviridae infections |
| 02/01/2007 | US20070027064 Pharmaceutical compositions for inhibiting metal ion dependent enzymatic activity and methods for the use thereof |
| 02/01/2007 | US20070027063 Method of preserving the function of insulin-producing cells |
| 02/01/2007 | US20070026512 Atomic structure of the catalytic domain for use in designing and identifying inhibitors of zap-70 kinase |
| 02/01/2007 | US20070026502 Specificity exchangers that redirect antibodies to a pathogen |
| 02/01/2007 | US20070026495 Novel Integrin Ligand ITGL-TSP |
| 02/01/2007 | US20070026494 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026492 Expression of G protein-coupled receptors with altered ligand binding and/or coupling properties |
| 02/01/2007 | US20070026491 Nucleotide sequences coding cytosine deaminase with enhanced ability to convert 5-fluorocytosine to its toxic form for use in treatment of cancer; antitumor agents |
| 02/01/2007 | US20070026487 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 02/01/2007 | US20070026486 chimera; nuclear factor kappa beta; vectors, host cell; gene therapy; pharmacokinetics |
| 02/01/2007 | US20070026485 Glycopegylation methods and proteins/peptides produced by the methods |
| 02/01/2007 | US20070026478 Hemiasterlin affinity probes and their uses |
| 02/01/2007 | US20070026470 Mammalian IAP gene family, primers, probes and detection methods |
| 02/01/2007 | US20070026464 Biologically active synthetic thyrotropin and cloned gene for producing same |
| 02/01/2007 | US20070026457 Screening method |
| 02/01/2007 | US20070026454 Human secreted proteins |
| 02/01/2007 | US20070026449 Novel human sodium-dependent phosphate cotransporter |
| 02/01/2007 | US20070026448 vectors, host cells, and recombinant and synthetic methods for producing said polypeptides; polypeptide has N-formyl peptide receptor activity |
| 02/01/2007 | US20070026445 Novel steroid-activated nuclear receptors and uses therefor |
| 02/01/2007 | US20070026437 Novel BMP products |
| 02/01/2007 | US20070026425 Hepatitis C virus Non-structural NS3/4A fusion gene |
| 02/01/2007 | US20070026422 Vaccine-induced hepatitis B viral strain and uses thereof |
| 02/01/2007 | US20070026396 Peptides directed against antibodies, which cause cold-intolerance, and the use thereof |
| 02/01/2007 | US20070026394 Modulation of gene expression associated with inflammation proliferation and neurite outgrowth using nucleic acid based technologies |
| 02/01/2007 | US20070026090 Treatment and prevention of inflammatory disease and mitochondrial dysfunction with high dose selenium |
| 02/01/2007 | US20070026088 a powder extracted from hardened antlers which contains 0.5 ng of insulin and insulin-like growth factor-I in the quantity of 18 ng per 1 g using ion exchange chromatography; hypoglycemic agent |
| 02/01/2007 | US20070026082 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 02/01/2007 | US20070026069 Biommetic hierarchies using functionalized nanoparticles as building blocks |
| 02/01/2007 | US20070026057 In vivo targeting of dendritic cells |
| 02/01/2007 | US20070026046 Neoglycopolymer-cross-linked biopolymer matrix |
| 02/01/2007 | US20070026045 Reinforced matrices |
| 02/01/2007 | US20070026044 Use of VEGF For Treating Bone Defects |
| 02/01/2007 | US20070026036 Drug/Drug Delivery Systems for the Prevention and Treatment of Vascular Disease |
| 02/01/2007 | US20070026027 Human chorionic gonadotropin (hCG) formulations for facilitating weight loss and body contouring |
| 02/01/2007 | US20070026017 Brachyspira pilosicoli 72kda outer-membrane protein and diagnostic and therapeutic uses thereof |
| 02/01/2007 | US20070026014 Interferon beta in severe acute respiratory syndrome (sars) |
| 02/01/2007 | US20070026008 Polypeptide comprising the immunogenic portion of wilms' tumor suppressor gene(wt1); tumor-associated antigen for use in cancer immunotherapy |
| 02/01/2007 | US20070026007 treatment of conditions characterized by a need to modulate migratory-cell movement associated with specific sites in a subject; isolating a stromal-cell-derived fugetactic agent |
| 02/01/2007 | US20070026005 Vaccine composition comprising il-12 adjuvant encapsulated in controlled-release microsphere |
| 02/01/2007 | US20070026001 APO-2 ligand-anti-her-2 antibody synergism |
| 02/01/2007 | US20070025999 Treatment with anti-vegf antibodies |
| 02/01/2007 | US20070025998 Methods for enhancing the efficacy of cancer therapy |
| 02/01/2007 | US20070025993 Tek antagonists |
| 02/01/2007 | US20070025991 Use of antagonists of ghrelin or ghrelin receptor to treat intestinal inflammation |
| 02/01/2007 | US20070025989 Administration of agents for the treatment of inflammation |
| 02/01/2007 | US20070025984 Treatment of ulcerative colitis with tropomyosin isoforms and monoclonal antibodies to tropomyosin isoforms |
| 02/01/2007 | US20070025983 Compounds capable of inhibiting HIV-1 infection |
| 02/01/2007 | US20070025979 Coagulation proteins, coagulation-anticoagulation protein complexes, derivatives thereof and their uses |
| 02/01/2007 | US20070025978 Bactiophage lysins for Enterococcus faecalis, Enterococcus faecium and other bacteria |
| 02/01/2007 | US20070025977 Method of treating steatorrhea in infants |
| 02/01/2007 | US20070025967 Zap protein and related compositions and methods |
| 02/01/2007 | US20070025966 With a sugar or polyethylene glycol; improved antiviral and immunomodulatory efficacy; HIV and hepatitis C vaccines |
| 02/01/2007 | US20070025965 Therapies for renal failure using interferon-beta |
| 02/01/2007 | US20070025964 administering an effective amount of beta -D-D4FC or its ester or salt to the human in combination or alternation with a second drug selected from abacavir, indinavir, nelfinavir, saquinavir, amprenavir, efavirenz, delavirdine, nevirapine for the treatment of an HIV infection in human |
| 02/01/2007 | US20070025963 Methods for reduction of scar tissue formation |
| 02/01/2007 | US20070025962 Interleukin-8 homologous polypeptides and therapeutic uses thereof |
| 02/01/2007 | US20070025961 Composition for stabilizing survival of transplanted hematopoietic stem cell, kit for obtaining the composition, method of stabilizing survival of transplanted hematopoietic stem cell, human monoclonal antibody or human polyclonal antibody and method of producing the same, gene encoding human monoclonal antibody and transf |
| 02/01/2007 | US20070025960 Bisphosphonates for prophylaxis and therapy against bioterrorism agents |
| 02/01/2007 | US20070025959 Adjuvant combination formulations |
| 02/01/2007 | US20070025958 Vaccine immunotherapy |
| 02/01/2007 | US20070025957 Vascular targeting of ocular neovascularization |
| 02/01/2007 | US20070025955 Tissue adhesive sealant |
| 02/01/2007 | US20070025924 Method of attenuating swelling or inflammation |
| 02/01/2007 | US20070025917 Optical imaging based on locally activated bioluminescence |
| 02/01/2007 | US20070025915 Determination of AM-binding proteins and the association of adrenomedullin (AM) therewith |
| 02/01/2007 | US20070025913 Immunoglobulin which specifically binds endothelial cell-specific polypeptides; for use as evaluative tool in immunodiagnostic and drug efficacy studies |
| 02/01/2007 | DE10141443B4 Verwendung von molekularbiologisch hergestellten, nicht-viralen Wirkstoffen zur Behandlung der Akne Using molecular biological manufactured, non-viral agents for the treatment of acne |
| 02/01/2007 | CA2617353A1 Graded expression of snail as marker of cancer development and dna damage-based diseases |
| 02/01/2007 | CA2617133A1 Compositions and methods for treating bacteria |
| 02/01/2007 | CA2616963A1 Stimulatory auto-antibodies to the pdgf receptor as pathology marker and therapeutic target |
| 02/01/2007 | CA2616877A1 Systems and methods for manufacturing liposomes |
| 02/01/2007 | CA2616805A1 Targeting-enhanced activation of galectins |
| 02/01/2007 | CA2616803A1 Peptidyl diacylglycerides |
| 02/01/2007 | CA2616789A1 Process for production of fermented milk and fermented milk beverage/food |
| 02/01/2007 | CA2616778A1 Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents |
| 02/01/2007 | CA2616537A1 Small compounds that correct protein misfolding and uses thereof |
| 02/01/2007 | CA2616521A1 Method of treating or preventing tissue deterioration, injury or damage due to congestive heart failure |
| 02/01/2007 | CA2616396A1 Growth hormone secretagogues |
| 02/01/2007 | CA2616345A1 Novel milk protein fractions and use thereof for preventing or treating chronic inflammatory diseases |
| 02/01/2007 | CA2616004A1 Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders |